Search

everythinglearnresearchcommunity

for

Search:↓

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Higher doses of cranial irradiation are linked to permanent hair loss.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Food-derived peptides may help prevent diseases like high blood pressure and high cholesterol, and can support the immune system.

Chronic hair diseases can severely affect mental health and self-confidence.

Chronic hair diseases can severely impact mental health and self-confidence.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Chemotherapy often causes hair loss, so patients should be counseled to reduce anxiety.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.